Clinical trial Recruiting at 1 site Interventional Ages 45 to 80

Collaborative VR versus screen-based VR for Parkinson's rehabilitation

Official title: COMPARATIVE EFFECTIVENESS of COLLABORATIVE VIRTUAL ENVIRONMENT and NON-IMMERSIVE VIRTUAL REALITY in the REHABILITATION of PATIENTS With PARKINSON'S DISEASE

Run by Superior University · NCT07523425 · Data updated 2026-11-12

This study tries two types of virtual-reality rehabilitation—therapist-guided collaborative VR versus screen-based non-immersive VR—for people with mild to moderate Parkinson's to see which improves movement, thinking, and quality of life over 12 weeks.

Quick facts

Study typeInterventional
Ages45 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorSuperior University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedMay 27, 2025
Main results expectedSeptember 27, 2026
Study endsSeptember 30, 2026
Registry record updatedApril 15, 2026
Trial IDNCT07523425 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 45–80 with idiopathic Parkinson's disease at Hoehn & Yahr stages I–III, on stable medication, with preserved cognition (MMSE ≥ 24), and able to take part in in-person virtual-rehabilitation sessions.

Probably not a fit

Patients with severe cognitive impairment, major visual/hearing/motor deficits unrelated to Parkinson's, epilepsy or other VR contraindications, severe musculoskeletal limitations, advanced comorbidities, or an inability/unwillingness to attend in-person sessions are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will assign people with mild to moderate Parkinson's disease to either a therapist-guided Collaborative Virtual Environment (CVE) or a non-immersive, screen-based virtual-reality (NIVR) program. Both groups will complete task-oriented, goal-directed exercises targeting motor and cognitive function across a 12-week intervention with graded progression and performance-based adjustments. Primary outcomes focus on standardized motor function scales, while secondary outcomes measure cognition, mobility, and quality of life. Sessions are delivered in-person at Punjab Institute of Neurosciences in Lahore, with eligibility limited to patients on stable medication and without severe cognitive or sensory impairments.

Why it matters

Potential benefit: If successful, the collaborative VR approach could produce greater improvements in motor control, engagement, and daily functioning than standard screen-based VR for people with mild to moderate Parkinson's.

How similar studies have gone: Prior studies of screen-based and immersive VR have shown benefits for motor and functional outcomes in Parkinson's, but therapist-guided collaborative VR is less well-studied and represents a relatively novel comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and Female
* Age: 45 years-80 Years
* Diagnosed patients of idiopathic Parkinson Disease with minor to moderate severity according to the Hoehn \& Yahr stages I-III.
* On conventional and stable medical treatment at present
* No severe cognitive impairments (MMSE ≥ 24).
* Ability to participate in virtual rehabilitation sessions
* Willingness to participate and provide informed consent

Exclusion Criteria:

* Severe visual, auditory, or motor impairments unrelated to Parkinson's.
* Fear of virtual environment.
* Comorbidities that hinder participation in the treatment (e.g., advanced dementia).
* Severe musculoskeletal conditions limiting movement
* History of epilepsy or conditions contraindicating virtual reality exposure
* Participation in another interventional study within the last 3 months

Where it's running

  • Punjab Institute of Neurosciences Lahore
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.